Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial
PsiquiatriaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Brain : a journal of neurology
- Publicado em
- 18 abr 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial
Hidenori Yamasue, Masaki Kojima, Hitoshi Kuwabara, Miho Kuroda, Kaori Matsumoto, Chieko Kanai, Naoko Inada, Keiho Owada, Keiko Ochi, Nobutaka Ono et al.
Descritores MeSH
- Autistic Disorder
- Autism Spectrum Disorder
- Animals
- Biological Availability
- Double-Blind Method
- Female
- Humans
- Male
- Oxytocin
- Rabbits
Veja também
Estudos relacionados
- Can repeated intranasal oxytocin administration affect reduced neural sensitivity towards expressive faces in autism? A randomized controlled trial
- The effect of oxytocin nasal spray on social interaction in young children with autism: a randomized clinical trial
- The neural effects of oxytocin administration in autism spectrum disorders studied by fMRI: A systematic review
- Evaluating placebo responses to intranasal oxytocin in autism: findings from the placebo lead-in phase of a randomised controlled trial